Immunohistochemistry-Enabled Precision Medicine
Author | Gatalica, Zoran |
Author | Feldman, Rebecca |
Author | Vranic, Semir |
Author | Spetzler, David |
Available date | 2019-08-22T11:21:44Z |
Publication Date | 2019-06-18 |
Publication Name | Precision Medicine in Cancer Therapy |
Identifier | http://dx.doi.org/10.1007/978-3-030-16391-4_4 |
Citation | Gatalica Z., Feldman R., Vranić S., Spetzler D. (2019) Immunohistochemistry-Enabled Precision Medicine. In: Von Hoff D., Han H. (eds) Precision Medicine in Cancer Therapy. Cancer Treatment and Research, vol 178. Springer, Cham |
Identifier | Chapter 4 |
Abstract | Immunohistochemistry (IHC) can be applied to diagnostic aspects of pathologic examination to provide aid in assignment of lineage and histologic type of cancer. Increasingly, however, IHC is widely used to provide prognostic and predictive (theranostic) information about the neoplastic disease. A refinement of theranostic application of IHC can be seen in the use of “genomic probing” where antibody staining results are directly correlated with an underlying genetic alteration in the tumor (somatic mutations) and/or the patient (germline constitution). All these aspects of IHC find their best use in guiding the oncologists in the optimal use of therapy for the patients. |
Language | en |
Publisher | Springer, Cham |
Subject | precision medicine biomarkers pathology immunohistochemistry |
Type | Book chapter |
Pagination | 111-135 |
Volume Number | 178 |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |
This item appears in the following Collection(s)
-
Medicine Research [1417 items ]